![Biao He](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Biao He is currently a Director at BioEclipse Therapeutics, Inc. He was previously a Venture Partner at Tsinghua Silicon Valley Capital.
| Sociétés | Poste | Début |
|---|---|---|
BioEclipse Therapeutics, Inc.
 BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops curative immune-oncology therapeutics | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Tsinghua Silicon Valley Capital
 Tsinghua Silicon Valley Capital Investment ManagersFinance TSVC invests in companies located in the United States. The firm focuses on deeptech, healthtech and data economy sectors. It participates in seed and early stage capital requirements. | Private Equity Investor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Tsinghua Silicon Valley Capital
Tsinghua Silicon Valley Capital Investment ManagersFinance TSVC invests in companies located in the United States. The firm focuses on deeptech, healthtech and data economy sectors. It participates in seed and early stage capital requirements. | Finance |
BioEclipse Therapeutics, Inc.
BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops curative immune-oncology therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
